Monday 19 October 2026
Export MOTS’s income statement to Excel — free account
Motus GI Holdings, Inc.
MOTS Healthcare Medical Devices
Motus GI Holdings, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $319,000.00, down 46.1% from fiscal 2022. Operating cash flow growth for three consecutive years.
0.00
0.00
NaN
Follow MOTS
| Older periods | Jun '23 | Sep '23 | Dec '23 | Mar '24 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
3 | 2 | 2 | 3 |
| (1,065.40%) | 1,601.86% | (454.34%) | (1,624.82%) | ||
| (100.74%) | (106.31%) | (103.47%) | (166.89%) | ||
ROIC |
(3,005.53%) | (854.19%) | (744,187.50%) | (1,411.26%) | |
Return on Tangible Assets |
(244.05%) | (414.73%) | (369.85%) | (482.38%) | |
Average Days of Receivables |
69.59 | 102.28 | 86.96 | 90.41 | |
Free Cash Flow per Share |
(30.34) | (21.55) | (13.95) | (0.98) | |
Free Cash Flow |
(15.29) | (13.49) | (11.30) | (8.41) | |
Capital Expenditures |
(0.26) | (0.11) | (0.10) | — | |
| Other line items | |||||
Cash ROIC |
(88.04%) | (108.49%) | (113.93%) | (81.60%) | |
Accounts Receivable Turnover |
5.95 | 2.77 | 4.73 | 4.92 | |
Accounts Payable Turnover |
0.43 | 0.36 | 0.30 | 0.27 | |
Inventory Turnover |
1.06 | 1.06 | 1.55 | 1.18 | |
Average Days of Payables |
680.04 | 709.67 | 1,181.60 | 1,340.72 | |
Days of Inventory on Hand |
206.32 | 197.02 | 157.16 | 204.47 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
923.74% | 1,169.23% | 1,086.83% | 754.74% | |
Selling, General and Administrative Expense of Revenue |
1,871.22% | 2,421.98% | 2,567.40% | 2,148.62% | |
Share Based Compensation of Revenue |
197.48% | 206.04% | 147.65% | 97.86% | |
Interest Coverage |
(7.54) | (7.03) | (15.65) | (15.90) | |
Operating CF/Net income |
0.94 | 0.97 | 0.87 | 0.52 | |
Depreciation/Fixed assets |
0.90 | 0.94 | 0.94 | 0.96 | |
Capex/Depreciation |
(0.24) | (0.11) | (0.11) | 0.00 | |
Revenue per Share |
1.10 | 0.58 | 0.39 | 0.04 | |
Operating CF per Share |
(29.82) | (21.37) | (13.82) | (0.98) | |
Capex per Share |
(0.52) | (0.18) | (0.13) | 0.00 | |
Capex to Sales |
0.47 | 0.31 | 0.33 | 0.00 |
Columns are period end dates